Bradley L Campbell - Net Worth and Insider Trading
Bradley L Campbell Net Worth
The estimated net worth of Bradley L Campbell is at least $9 Million dollars as of 2024-11-29. Bradley L Campbell is the President and CEO of Amicus Therapeutics Inc and owns about 886,654 shares of Amicus Therapeutics Inc (FOLD) stock worth over $9 Million. Details can be seen in Bradley L Campbell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bradley L Campbell has not made any transactions after 2024-11-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bradley L Campbell
Bradley L Campbell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bradley L Campbell owns 4 companies in total, including Amicus Therapeutics Inc (FOLD) , ARYA Sciences Acquisition Corp III (ARYA) , and Progenics Pharmaceuticals Inc (PGNX) among others .
Click here to see the complete history of Bradley L Campbell’s form 4 insider trades.
Insider Ownership Summary of Bradley L Campbell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FOLD | Amicus Therapeutics Inc | 2024-11-06 | director & President and CEO |
ARYA | ARYA Sciences Acquisition Corp III | 2020-08-06 | director |
PGNX | Progenics Pharmaceuticals Inc | 2020-06-19 | director |
2020-08-06 | director |
Bradley L Campbell Latest Holdings Summary
Bradley L Campbell currently owns a total of 1 stock. Bradley L Campbell owns 886,654 shares of Amicus Therapeutics Inc (FOLD) as of November 6, 2024, with a value of $9 Million.
Latest Holdings of Bradley L Campbell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FOLD | Amicus Therapeutics Inc | 2024-11-06 | 886,654 | 9.96 | 8,831,074 |
Holding Weightings of Bradley L Campbell
Bradley L Campbell Form 4 Trading Tracker
According to the SEC Form 4 filings, Bradley L Campbell has made a total of 67 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 67 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 7,901 shares on November 6, 2024, which brought Bradley L Campbell around $98,763.
Insider Trading History of Bradley L Campbell
- 1
Bradley L Campbell Trading Performance
Bradley L Campbell Ownership Network
Bradley L Campbell Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Bradley L Campbell is the director & President and CEO of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & Executive Chairman John F Crowley , Chief People Officer David Michael Clark , and General Counsel & Corp. Secy Ellen Rosenberg .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Bradley L Campbell made 23 insider transaction in Amicus Therapeutics Inc (FOLD) with a net sale of 232,762. Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 327,191 shares made by John F Crowley , a net sale of 95,000 shares made by Ellen Rosenberg , and a net sale of 76,672 shares made by Samantha Prout .
In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 797,737 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 797,737 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Bradley L Campbell Mailing Address
Above is the net worth, insider trading, and ownership report for Bradley L Campbell. You might contact Bradley L Campbell via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.